Kamada

KMDA NASDAQ
5.90
+0.04
+0.68%
已收盘, 16:00 07/16 EDT
开盘
5.92
昨收
5.86
最高
5.92
最低
5.84
成交量
3.99万
成交均量(3M)
5.31万
52周最高
6.70
52周最低
4.633
换手率
0.10%
市值
2.38亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Kamada KMDA股票价格,Kamada股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology. It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company’s product line includes intravenous AAT for chronic replacement therapy in individuals with congenital alpha-1 antitrypsin deficiency; KamRAB for prophylaxis of rabies infection; KamRho-D IM for prophylaxis of Rh hemolytic disease of the newborn; KamRho-D IV for treatment of immune thrombocytopenic purpura; and IVIG, a replacement therapy in primary and secondary immune therapy. Its product line also comprises Protosol to reduce blood loss in patients undergoing cardiac surgery; Heparin sodium injection for coagulation inhibition and prophylaxis of thromboembolic diseases and Heparin Lock Flush to maintain potency of intravenous injection device among other.
展开 >

最近浏览

名称
价格
涨跌幅